Your session is about to expire
← Back to Search
3D Printed Oral Stents for Head and Neck Cancers
Study Summary
This trial looks at whether 3D-printed oral tents can help reduce mouth blisters and sores for patients receiving head and neck radiation therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I will be treated with radiotherapy and either cisplatin, carboplatin, or cetuximab.My cancer is in the maxillary sinus and doesn't affect my mouth or throat.My cancer is located at the base of my tongue.I will be treated with radiotherapy and either cisplatin, carboplatin, or cetuximab.I am 18 years old or older.My cancer is located in my nasal cavity and does not affect my mouth or throat.I am 18 years old or older.My tonsil cancer is on one side without affecting the soft palate and qualifies for one-sided radiotherapy.My parotid cancer is on one side and qualifies for targeted radiation therapy.I am able to get out of my bed or chair and move around.I am able to get out of my bed or chair and move around.My cheek cancer is on one side and qualifies for targeted radiation therapy.I have had radiotherapy for head or neck cancer.I can barely open my mouth (less than the width of a pencil).My cheek cancer is on one side and qualifies for targeted radiation therapy.I have a specific type of throat cancer and am set to receive targeted radiation therapy.My parotid cancer is on one side and qualifies for targeted radiation therapy.My cancer affects the maxillary sinus but not my mouth or throat.My cancer is located at the base of my tongue.I am younger than 18 years old.I am set to receive radiotherapy for my head or neck cancer.My cancer is in the nasal cavity and doesn't affect my mouth or throat.
- Group 1: Arm I (3D printed oral stent)
- Group 2: Arm II (standard of care)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How extensive is the participant base of this clinical study?
"Affirmative. Clinicaltrials.gov records support the assertion that, as of October 10th 2022, this trial is still in need of 93 participants from 4 sites. The study was initially published on May 26 2021 and has been modified since then."
How many venues are there for participating in this clinical investigation?
"This clinical trial is currently being managed from Banner Health/Banner Research in Phoenix, Arizona; M D Anderson Cancer Center in Houston, Texas; Cooper Hospital University Medical Center in Camden, New jersey; and four other establishments."
Are there any opportunities for participants to take part in this medical experiment?
"According to the clinicaltrials.gov website, this experiment is still recruiting participants; it was first published on May 26th 2021 and its details were modified lastly on October 10th 2022."
Share this study with friends
Copy Link
Messenger